Diabetes Pro Quarterly - Spring 2017 - 15

RESEARCH NEWS

Nomination Deadline Approaching for 2018 Pathway to Stop Diabetes®
Grant Opportunity
Pathway to Stop Diabetes focuses on brilliant minds
at the peak of their creativity, providing 5- to 7-year
grants of $1.625 million and the freedom, autonomy,
and professional mentoring to drive new breakthroughs
in the fight to stop diabetes.
Now in its fifth year of accelerating science and empowering talent, Pathway is bringing new perspectives
to diabetes research by supporting innovative basic,
clinical, translational, epidemiological, and health
services research that is relevant to any type of diabetes,
diabetes-related disease state, or complication.
The American Diabetes Association is currently accepting nominations for 2018 Pathway awards.
Nominations: Nominations are invited from U.S. accredited academic and nonprofit research institutions.
* Each institution is allowed a single nomination for
any of the three award mechanisms offered.

* Individual components of multicomponent organizations* with unique DUNS/IPF identifiers are
considered independent institutions.
* Nomination of individuals from diverse backgrounds,
including minority groups that are underrepresented
in biomedical research,† is strongly encouraged.
*e.g., individual campuses within the University of
California system, affiliated institutions within the
Harvard system
†Underrepresented minorities are defined as African
American or Black, Hispanic/Spanish/Latino,
American Indian/Alaskan Native or Native Hawaiian/
Pacific Islander.
Deadline: July 3, 2017, for January 2018 funding.
For more information about Pathway, please visit
diabetes.org/pathway.

Pathway to Stop Diabetes Symposium to be Held at 77th Scientific
Sessions in San Diego
The American Diabetes Association's Pathway to Stop
Diabetes initiative has funded four classes of researchers to date, and these Pathway scientists are already
making remarkable contributions to the field of diabetes research. In response to tremendous interest in their
work, there will be an open-access session at this year's
scientific sessions featuring Pathway awardees.

ADA PATHWAY TO STOP DIABETES SYMPOSIUM
Saturday, June 10
1:45-3:45 p.m. San Diego Convention Center, Room 31
Hear the latest updates from six Pathway awardees, who
will deliver short lectures during this symposium.
Attendees will hear about using nanotechnology to improve wound healing in diabetes; a novel approach to

targeting diet-induced obesity through the nervous
system; the intersection of diet and intestinal stem
cells in regulating metabolism; the effects of maternal
obesity and gestational diabetes on obesity in children;
how high levels of certain dietary metabolites are linked
to impaired glucose and lipid metabolism; and an engineering-based delivery system for automated insulin
release via a wearable patch.
The American Diabetes Association thanks Pathway
program sponsors Novo Nordisk, Sanofi, AstraZeneca,
Merck, and the Eli Lilly and Company Foundation, and
the numerous other generous corporations, individuals,
and foundations who have collectively donated more
than $40 million to support this effort.

Association Grant Reporting Deadlines
Core Program
Grants starting on July 1

Financial reports due August 1, 2017

Grants ending on June 30, 2017

Final reports due September 1, 2017

DIABETESPRO QUARTERLY

http://www.diabetes.org/pathway

Table of Contents for the Digital Edition of Diabetes Pro Quarterly - Spring 2017